Home / Stocks / NBIX

NBIX insider trading

NEUROCRINE BIOSCIENCES INC — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-13Lippoldt Darin
Chief Legal Officer
Sold10,000$179.60$1.8M
2026-07-09Delaet Ingrid
Chief Regulatory Officer
Sold8,433$178.72$1.5M
2026-06-30Lippoldt Darin
Chief Legal Officer
Sold8,110$170.03$1.4M
2026-06-09SHERWIN STEPHEN A
Director
Sold14,779$164.73$2.4M
2026-06-04Cooke Julie
Chief Human Resources Officer
Sold23,735$155.95$3.7M
2026-06-02Onyia Jude
Chief Scientific Officer
Sold11,000$160.25$1.8M
2026-05-29Onyia Jude
Chief Scientific Officer
Sold11,000$155.53$1.7M
2026-05-21GORMAN KEVIN CHARLES
Director
Sold245,088$154.33$37.8M
2026-05-18POPS RICHARD F
Director
Sold15,000$157.65$2.4M
2026-01-20Gano Kyle
Chief Executive Officer
Sold34,588$132.70$4.6M
2025-12-04LYONS GARY A
Director
Sold15,000$152.61$2.3M
2025-11-26MORROW GEORGE J
Director
Sold15,000$143.37$2.2M
2025-11-06RASTETTER WILLIAM H
Director
Sold18,000$151.82$2.7M
2025-08-11GORMAN KEVIN CHARLES
Director
Sold106,322$126.41$13.4M
2025-07-11Onyia Jude
Chief Scientific Officer
Sold59,819$130.46$7.8M
2025-07-07Onyia Jude
Chief Scientific Officer
Sold20,362$130.13$2.6M
2025-05-29GORMAN KEVIN CHARLES
Director
Sold9,613$120.38$1.2M
2025-05-07RASTETTER WILLIAM H
Director
Sold30,000$110.20$3.3M
2025-02-14SHERWIN STEPHEN A
Director
Sold13,831$116.69$1.6M
2025-01-29GORMAN KEVIN CHARLES
Director
Sold146,105$149.46$21.8M
2025-01-17Gano Kyle
Chief Executive Officer
Sold60,188$141.50$8.5M

See NBIX on the chart

Every insider buy and sell for NBIX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.